Immunization in developing countries

Vaccines

Volumn , Issue , 2008, Pages 1541-1571

  Hadler, Stephen C ^a   Dietz, Vance ^b   Okwo Bele, Jean Marie ^a   Cutts, Felicity T ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350572656     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3611-1.50074-x     Document Type: Chapter

References (356)

1. RH Henderson (1995) Vaccination: successes and challenges. FT Cutts, PG Smith (Eds) Vaccination and World Health Chichester, England: John Wiley 3-16.
2. MA Miller and AR Hinman (2004) Economic analysis of vaccine policies. SA Plotkin, WA Orenstein (Eds) Vaccines 4th edn Philadelphia, PA: Elsevier [Chapter 57]
3. DE Bloom, D Canning and M Weston (2005) The value of vaccination. World Economics 6 15-39.
4. World Health Organization and United Nations Children's Fund (2003) State of the World's Vaccines and Immunization Geneva: World Health Organization
5. O. World Health Organization (2006) 2005 Global Immunization data Geneva, Switzerland: World Health Organization Available at http://www.who.int/immunization_monitoring/data/SlidesGlobalImmunization.pdf
6. CJL Murray, AD Lopez, CD Mathers and C Stein (2001) The Global Burden of Disease 2000 Project: Aims, Methods, and Data Sources (Global Programme on Evidence for Health Policy Discussion Paper No 36) Geneva: World Health Organization
7. World Health Organization and United National Children's Fund Global Immunization Vision and Strategy, 2006–2015. Geneva, Switzerland: World Health Organization and United National Children's Fund, 2005.(WHO/IVB/05.05). Available at http//www.who.int/vaccines/GIVS/English/GIVS_final_17Oct05.pdf
8. O. World Health Organization (2006) Challenges in global immunization and the Global Immunization Vision and Strategy, 2006–2015. Wkly Epidemiol Rec 81 190-195.
9. CJD Murray and AD Lopez Global Burden of Disease, 2001 Update. World Health Organization, 2001. Available at www.who.int
10. Expanded Programme on Immunisation (2006) Progress towards the global eradication of poliomyelitis, 2005. Wkly Epidemiol Rec 81 164-172.
11. Expanded Programme on Immunisation (2006) Progress in reducing global measles deaths, 1999–2004. Wkly Epidemiol Rec 81 90-94.
12. Global Alliance for Vaccines and Immunization (2000) Second GAVI Board Meeting, January 2000 (GAVI/00.01) Geneva: World Health Organization
13. I Hardy, S Dittman and R Sutter (1996) Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet 347 1739-1744.
14. S Dittmann, M Wharton, C Vitek, et al. (2000) Successful control of epidemic diphtheria in the states of the former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 181(suppl 1), S10-S22.
15. TP Monath (2001) Yellow fever: an update. Lancet Infect Dis 1 11-20.
16. O. World Health Organization (2005) Progress in the control of yellow fever in Africa. Wkly Epidemiol Record 80 50-55.
17. O. World Health Organization (2006) Conclusions and recommendations from the immunization strategic advisory group. Wkly Epidemiol Rec 81 2-11.
18. S Chunharas (1995) The role of epidemiology in the development of a vaccination programme: discussion. FT Cutts, PG Smith (Eds) Vaccination and world health Chichester, England: John Wiley 138-144.
19. World Health Organization WHO vaccine preventable diseases: monitoring system:2006 Global summary. World Health Organization; 2006. WHO/IVB/2006. Available at http//:www.who.int/vaccines-documents/globalsummary/globalsummary.pdf
20. P Khaleghian (2004) Decentralization and public services: the case of immunization. Soc Sci Med 59 163-183.
21. IA Semali, M Tanner and D de Savigny (2005) Decentralizing EPI services and prospects for increasing coverage: the case of Tanzania. Int J Health Plann Manage 20 21-39.
22. S Atkinson and J Cheyne (1994) Immunisation in urban areas: issues and strategies. Bull World Health Organ 72 183-194.
23. JB Schwartz and I Bhushan (2004) Improving immunization equity through a public-private partnership in Cambodia. Bull World Health Organ 82 661-667.
24. K Keja, C Chan, G Hayden and RH Henderson (1988) Expanded programme on immunization. World Health Stat Q 41 59-63.
25. N Begg and FT Cutts (1995) The role of epidemiology in the development of a vaccination programme. FT Cutts, PG Smith (Eds) Vaccination and world health Chichester, England: John Wiley 123-138.
26. WR Dowdle and DR Hopkins (1998) The eradication of infectious diseases: Dahlem Workshop Report Chichester, England: John Wiley
27. Goodman RA, Foster KL, Trowbridge FL, Figueroa JP (eds). Global disease elimination and eradication as public health strategies: Proceedings of a conference held in Atlanta, GA USA, 23–25 February 1998. Bull World Health Organ 76(suppl 2):1–162, 1998.
28. Centers for Disease Control and Prevention (1993) Recommendations of the International Task Force for Disease Eradication. MMWR 42(RR-16), 1-38.
29. World Health Organization Draft Global Immunization Strategy. Fifty-Eight World Health Assembly, Agenda item 13.8, WHA 58.15. World Health Organization 25 May 2005. www.who.int/gb/ebwha/pdf_files/WHA58/WHA58_15pdf
30. UNICEF Draft Global Immunization Strategy, Note by the Secretariat. United Nations Children's Fund Executive Board annual session 2005, Item 11 of the provisional agenda. http://www.unicef.org/about/execboard/files/05-9_UNICEF-WHO.pdf
31. UNICEF A world fit for children: Millenium development goals. Special session on children documents: the convention on the rights of the child. July 2002. www.unicef.org/publications/index_4445.html
32. Global Programme for Vaccines and Immunisation, Expanded Programme on Immunisation (1996) Immunization Policy (WHO/EPI/GEN/95.03 Rev. 1) Geneva: World Health Organization
33. Vaccines, Immunization & Biologicals (2003) Case Information for the Development of Immunization Policy (WHO/V&B/02.28) Geneva: World Health Organization
34. Global Program on Vaccines and Immunization Position Papers on Vaccines. published in Weekly Epidemiol Rec. and available at http://www.who.int/immunization/documents/positionpapers_intro/en/index.html
35. Centers for Disease Control and Prevention (2002) General recommendations on immunization. MMWR 51(RR-2), 1-36.
36. O. World Health Organization (2006) Diphtheria vaccine—WHO position paper. Wkly Epidemiol Rec 81 24-32.
37. P Prempree, S Chitpitaklert and N Silarug (1996) Diphtheria outbreak–Saraburi province, Thailand. MMWR 45 271-273.
38. Y Youwang, D Jianming, X Yong and Z Pong (1992) Epidemiological features of an outbreak of diphtheria and its control with diphtheria toxoid immunization. Int J Epidemiol 21 807-811.
39. O. World Health Organization (1999) Pertussis vaccines. Wkly Epidemiol Record 74 137-144.
40. J Cherry and P Olin (1999) The science and fiction of pertussis vaccines. Pediatrics 104 1381-1384.
41. WK Yih, SM Lett, FN des Vignes, et al. (2000) The increasing incidence of pertussis in Massachusetts’ adolescents and adults, 1989–1998. J Infect Dis 182 1409-1416.
42. O. World Health Organization (2005) Pertussis vaccines—WHO position paper. Wkly Epidemiol Rec 80 31-39.
43. Centers for Disease Control and Prevention (2006) Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid. Reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices. MMWR 55(RR03), 1-34.
44. S Kubit, S Czajka, T Olakowska and Z Piasecki (1983) Evaluation of the effectiveness of BCG vaccinations. Pediatr Pol 47 777-781.
45. L Lugosi (1987) Analysis of the efficacy of mass BCG vaccination from 1959 to 1983 in tuberculosis control in Hungary. Bull Int Union Tuberc 16 15-34.
46. P Fine and D Clayton (1996) Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 348 17-24.
47. LC Rodrigues, SM Pereira, SS Cunha, B Genser, MY Ichihara, SC de Brito, MA Hijjar, I Dourado, AA Cruz, C Sant’Anna, AL Bierrenbach and ML Barreto (2005) Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 366(9493), 1290-1295.
48. Global Tuberculosis Programme and Global Programme on Vaccines (2004) BCG vaccine—WHO position paper. Wkly Epidemiol Rec 79 27-38.
49. FT Cutts, O Monteiro, P Tabard and J Cliff (1994) Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months. Bull World Health Organ 72 227-231.
50. O. World Health Organization (2000) Strategies for reducing global measles mortality. Wkly Epidemiol Rec 75 409-416.
51. LE Markowitz, SR Preblud, PEM Fine and WA Orenstein (1990) Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 9 101-110.
52. CA de Quadros (1995) Strategies for disease control/elimination in the Americas. FT Cutts, PG Smith (Eds) Vaccination and World Health Chichester, England: John Wiley 17-34.
53. O. World Health Organization (2005) Influenza vaccines. WHO position paper. Wkly Epidemiol Rec 80 279-287.
54. Centers for Disease Control and Prevention (2006) Recommended Adult Immunization Schedule—United States, October 2006–September 2007. Recommendations of the Advisory Committee on Immunization Practices. MMWR 55(40), Q1-Q4.
55. Gillberg C, Heijbel H. MMR and autism. Autism 2:423–424, 1998.
56. H Lundbeck, B Hakansson, JS Lloyd, et al. (1978) A cold box for the transport and storage of vaccines. Bull World Health Organ 56 427-432.
57. Expanded Programme on Immunisation (1984) Ice-lined refrigerators (ILR). Wkly Epidemiol Rec 59 63-64.
58. World Health Organization and United Nations Children's Fund (2000) Product Information Sheets, 2000 Edition (WHO/V&B/00.13) Geneva: World Health Organization
59. Vaccines, Immunization & Biologicals (1999) Temperature Monitors for Vaccines and the Cold Chain (WHO/V&B/99.15) Geneva: World Health Organization
60. CM Nelson, et al. (2004) Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. Bull World Health Organ 82 99-105.
61. M Zaffran (1996) Vaccine transport and storage: environmental challenges. Dev Biol Stand 87 9-17.
62. Expanded Programme on Immunization (2000) The Use of Open Vials of Vaccines in Subsequent Immunization Sessions: World Health Organization Policy Statement (WHO/V&B/00.09) Geneva: World Health Organization
63. World Health Organization and United Nations Children's Fund (1999) Quality of the Cold Chain-WHO/UNICEF Policy Statement on the Use of Vaccine Vial Monitors in Immunization Practices (WHO/V&B/99.18) Geneva: World Health Organization
64. DB Hipgrave, JE Maynard and B Biggs (2006) Improving birth dose coverage of hepatitis B vaccine. Bull World Health Organ 84 65-71.
65. M Dicko (2000) Safety of immunization injections in Africa: not simply a problem of logistics. Bull World Health Organ 78 163-169.
66. L Simonsen, A Kane, J Lloyd, et al. (1999) Unsafe injections in the developing world and transmission of blood-borne pathogens. Bull World Health Organ 77 789-800.
67. A Hauri, G Armstrong and YTF Hutin (2003) Estimation of the global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 15 7-16.
68. Vaccines, Immunization & Biologicals (2002) ‘First Do No Harm.’ Introducing Auto-Disable Syringes and Ensuring Injection Safety in Immunization Systems of Developing Countries (WHO/V&B/02.26) Geneva: World Health Organization
69. PEM Fine (1993) Herd immunity: history, theory, practice. Epidemiol Rev 15 265-302.
70. JD Walley and M McDonald (1991) Integration of mother and child health services in Ethiopia. Trop Doct 215 32-35.
71. B Tandon and N Gandhi (1992) Immunization coverage in India for areas served by the Integrated Child Development Services programme. Bull World Health Organ 70 461-465.
72. D Hull (1987) Why children are not immunized. J R Coll Physicians Lond 21 28-31.
73. F Cutts, W Orenstein and R Bernier (1992) Causes of low preschool immunization coverage in the United States. Annu Rev Public Health 13 385-398.
74. SO Foster (1993) Immunization in 12 African countries 1982–1993. In Centers for Disease Control. Africa Child Survival Initiative-Combating Childhood Communicable Diseases New York: U.S. Agency for International Development, World Health Organization, and United Nations Children's Fund
75. S Foster (1989) Immunization opportunities taken and missed. Rev Infect Dis 11(suppl), S629-S630.
76. S Hutchins, H Jansen, S Robertson, et al. (1993) Studies of missed opportunities for immunization in developing and industrialized countries. Bull World Health Organ 71 549-560.
77. Expanded Programme on Immunisation (1991) Training for Mid Level Managers: Identify Missed Opportunities (WHO/EPI/MLM/91.7) Geneva: World Health Organization
78. D Levy-Bruhl, A Soucat, S Diallo, et al. (1994) Integration du PEV aux soins de santé primaires: l’exemple du Benin et de la Guinée. Cah Santé 4 205-212.
79. TJ John and MC Steinhoff (1981) Appropriate strategy for immunization of children in India. 3. Community-based annual pulse (cluster) immunization. Indian J Pediatr 48 677-683.
80. FT Cutts, S Kortbeek, R Malalane, et al. (1988) Developing appropriate strategies for EPI: a case study from Mozambique. Health Policy Plan 3 291-301.
81. SO Foster, RA Spiegel, A Mokdad, et al. (1993) Immunization, oral rehydration therapy and malaria chemotherapy among children under 5 in Borni and Grand Cape Mount counties, Liberia, 1984 and 1988. Int J Epidemiol 22(suppl 1), S50-S55.
82. Vaccines, Immunization & Biologicals (2002) Sustainable Outreach Services (SOS): A Strategy for Reaching the Unreachable with Immunization and Other Services (WHO/V&B/00.37) Geneva: World Health Organization
83. J Gindler, FT Cutts, ME Barnett-Antinori, et al. (1993) Successes and failures in vaccine delivery: evaluation of the immunization delivery system in Puerto Rico. Pediatrics 91 315-320.
84. MD Malison, P Sekeito, PL Henderson, et al. (1987) Estimating health service utilization, immunization coverage, and childhood mortality: a new approach in Uganda. Bull World Health Organ 65 325-330.
85. C Auer and M Tanner (1990) Childhood vaccination in a squatter area of Manila: coverage and providers. Soc Sci Med 31 1265-1270.
86. F Cutts (1991) Strategies to improve immunization services in urban Africa. Bull World Health Organ 69 407-414.
87. D Fassin, E Jeannee, D Cebe and M Reveillon (1988) Who consults and where? Sociocultural differentiation in access to health care in urban Africa. Int J Epidemiol 17 858-864.
88. D Fassin and E Jeannee (1989) Immunization coverage and social differentiation in urban Senegal. Am J Public Health 79 509-511.
89. F Cutts, M Phillips, S Kortbeek and A Soares (1990) Door-to-door canvassing for immunization program acceleration in Mozambique: achievements and costs. Int J Health Serv 20 717-725.
90. MGG Romero, ES Pizano and JA Lamo (1985) Channelling, a new immunization strategy. Assoc Children 69/72 193-203.
91. H Saeed (1989) Increasing vaccine coverage through new delivery systems: a Sudan approach. Rev Infect Dis 11(suppl), S644-S645.
92. ME Taylor, FM Laforce, RN Basu, et al. (1996) Sustainability of Achievements: Lessons Learned from Universal Child Immunization. Report of a Steering Committee New York: United Nations Children's Fund 105.
93. J-P Unger (1991) Can intensive campaigns dynamize front line health services? The evaluation of an immunization campaign in Thies health district, Senegal. Soc Sci Med 32 249-259.
94. J-P Unger and JR Killingsworth (1986) Selective primary health care: a critical review of methods and results. Soc Sci Med 22 1001-1013.
95. C Waddington and H Goodman (1995) Does economic analysis affect vaccination policy. FT Cutts, PG Smith (Eds) Vaccination and World Health Chichester, England: John Wiley 163-173.
96. D Banerji (1988) Hidden menace in the universal child immunization program. Int J Health Serv 18 293-299.
97. FT Cutts, DC Glik, A Gordon, et al. (1990) Application of multiple methods to study the immunization programme in an urban area of Guinea. Bull World Health Organ 68 769-776.
98. F Godlee (1995) WHO's Special Program: undermining from above. BMJ 310 178-182.
99. AD du Lou and G Pison (1994) Barriers to universal child immunization in rural Senegal 5 years after the accelerated Expanded Programme on Immunization. Bull World Health Organ 72 751-759.
100. JW Bryce, FT Cutts and S Saba (1990) Mass immunization campaigns and quality of immunization services. Lancet 335 739-740.
101. CA de Quadros, JM Olive, BS Hersh, et al. (1996) Measles elimination in the Americas: evolving strategies. JAMA 275 224-229.
102. Global Programme for Vaccines of the World Health Organization (1994) Role of mass campaigns in global measles control. Lancet 344 174-175.
103. V Dietz and F Cutts (1997) The use of mass campaigns in the Expanded Programme on Immunization: a review of reported advantages and disadvantages. Int J Health Serv 27 767-790.
104. Pan American Health Organization (1995) The Impact of the Expanded Programme on Immunization and the Polio Eradication Initiative on Health Systems in the Americas Washington: DC, Pan American Health Organization
105. P Ching, M Birmingham, T Goodman, et al. (2000) Childhood mortality impact and costs of implementing vitamin A supplementation into immunization campaigns. Am J Public Health 90 1526-1529.
106. T Goodman, N Dalmiya, B de Benoist and W Schultink (2000) Polio as a platform: using national immunization days to deliver vitamin A supplements. Bull World Health Organ 78 305-314.
107. Integration of vitamin A supplementation with immunizations (1999) Wkly Epidemiol Rec 74 1-6. Available at www.who.int/wer/pdf/1999/wer2001.pdf
108. CDC (2005) Distribution of Insecticide-Treated Bednets During an Integrated Nationwide Immunization Campaign—Togo, West Africa, December 2004. MMWR 54 994-996.
109. PAHO Third Annual Vaccination Week in the Americas. Final Report. 24–30 April 2005. Available at http://www.paho.org/English/AD/FCH/IM/FinalReport_VWA2005.pdf
110. P Poore (1987) A global view of immunization. J Roy Coll Physicians Lond 21 22-28.
111. S Cairncross, H Peries and F Cutts (1997) Vertical health programmes. Lancet 349(suppl iii), siii20-siii22.
112. S Murugasampillay (1995) Who determines national health policies. FT Cutts, PG Smith (Eds) Vaccination and World Health Chichester, England: John Wiley 195-205.
113. PM Ndumbe (1995) Do vaccines reach those who most need them? Cameroon. FT Cutts, PG Smith (Eds) Vaccination and World Health Chichester, England: John Wiley 225-238.
114. L Chen and R Cash (1988) A decade after Alma Ata-can primary health care lead to health for all? N Engl J Med 319 946-947.
115. Expanded Programme on Immunisation (1992) Global Advisory Group-part I. Wkly Epidemiol Rec 3 11-15.
116. CA de Quadros, JK Andrus, JM Olive and GC deMacedo (1992) Polio eradication from the Western Hemisphere. Annu Rev Public Health 13 239-252.
117. O. World Health Organization (1988) Global eradication of poliomyelitis by the year 2000. Wkly Epidemiol Rec 63 161-162.
118. CA de Quadros, BS Hersh, JM Olive, et al. (1997) Eradication of wild poliovirus from the Americas: acute flaccid paralysis surveillance, 1988–1995. J Infect Dis 175(suppl 1), S37-S42.
119. HF Hull, NA Ward, BP Hull, et al. (1994) Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 343 1331-1337.
120. OM Kew, RW Sutter, E de Gourville, et al. (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59 587-635.
121. Advisory Committee on Polio Eradication (2005) Standing recommendations for responding to circulating polioviruses in polio-free areas. Weekly Epidemiol Record 80 330-331.
122. World Health Organization, WHO Global action plan for laboratory containment of wild polioviruses. Vaccines and Biologicals, Geneva, 2003 (WHO/V&B/03.11).
123. Centers for Disease Control and Prevention (1998) Advances in global measles control and elimination: summary of the 1997 international meeting. MMWR 47(RR-11), 1-23.
124. World Health Organization and United Nations Children's Fund (2001) Measles Mortality Reduction and Regional Elimination: Strategic Plan, 2001–2005 (WHO/V&B/01.13) Geneva: World Health Organization
125. WHO and UNICEF. WHO/UNICEF Joint Statement: Global plan for reducing measles mortality 2006–2010. Geneva 2005 (WHO/IVB/05.11).
126. PAHO XVI Meeting of the Technical Advisory Group on Vaccine Preventable Diseases, Mexico City. 3–5 November 2004. Final Report. Available at http://www.paho.org/English/AD/FCH/IM/TAG16_FinalReport_2004.pdf
127. PAHO 44 th Directing Council. Washington, D.C. 22–26 September 2003. CD/44/11. Available at http://www.paho.org/english/gov/cd/cd44-11-e.pdf
128. World Health Organization, United Nations Children's Fund, and United Nations Population Fund (2002) Maternal and Neonatal Tetanus Elimination by 2007: Strategy for Achieving and Monitoring Elimination (WHO/V&B/02.09) Geneva: World Health Organization
129. O. World Health Organization (2006) Tetanus vaccine—WHO position paper. Weekly Epidemiol Record 81 198-208.
130. F Cutts, A Soares, A Jecque, et al. (1990) The use of evaluation to improve the Expanded Programme on Immunization in Mozambique. Bull World Health Organ 68 199-208.
131. DA Henderson (1987) Principles and lessons from the smallpox eradication programme. Bull World Health Organ 65 535-546.
132. R Henderson and J Keja (1989) Global control of vaccine-preventable diseases: how progress can be evaluated. Rev Infect Dis 11(suppl), S649-S654.
133. Vaccines, Immunization & Biologicals WHO/UNICEF Joint Reporting Form on Vaccine Preventable Diseases, 2005. http://Available at www.who.int/immunization_monitoring/Joint_reporting/en/index.html
134. RM Weeks, F Svetlana, S Noorgoul, et al. (2000) Improving the monitoring of immunization services in Kyrgystan. Health Policy Plan 15 279-286.
135. B. Vaccines and Biologicals (2004) The immunization data quality audit (DQA) procedure. World Health Organization, Geneva, 2003 (WHO/V&B/03.19) and The immunization data quality self-assessment (DQS) tool Geneva: World Health Organization (WHO/IVB/05.04).
136. O Ronveaux, D Rickert, S Hadler, et al. (2005) The immunization data quality audit: verifying the quality and consistency of immunization monitoring systems. Bull World Health Org 83 503-510.
137. B. Vaccines and Biologicals (2003) Monitoring vaccine wastage at the country level. Guidelines for programme managers Geneva: World Health Organization (WHO/V&B/03.18).
138. MW Borgdorff and GJA Walker (1988) Estimating vaccination coverage: routine information or sample survey? J Trop Med Hyg 91 35-42.
139. CJ Murray, B Shengelia, N Gupta, et al. (2003) Validity of reported vaccination coverage in 45 countries. Lancet 362 1022-1027.
140. P Singh and RJ Yadav (2000) Immunization status of children in India. Indian Pediatr 37 1194-1199.
141. RH Henderson and T Sundaresan (1982) Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ 60 253-260.
142. RE Serfling, RG Cornell and IL Sherman (1960) The CDC quota sampling technique with results of 1959 poliomyelitis vaccination surveys. Am J Public Health 50 1847-1857.
143. S Bennett, T Woods, WM Liyanage and DL Smith (1991) A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q 44 98-106.
144. Immunizations, Vaccines and Biologicals (2004) Immunization cluster coverage survey—reference manual Geneva: World Health Organization (WHO/IVB/04.23).
145. A Friede, C Waternaux, B Guyer, et al. (1985) An epidemiological assessment of immunization programme participation in the Philippines. Int J Epidemiol 14 135-142.
146. F Brugha, J Kevany and A Swan (1996) An investigation of the role of fathers in immunization uptake. Int J Epidemiol 25 840-845.
147. R Brugha and J Kevany (1996) Maximizing immunization coverage through home visits: a controlled trial in an urban area of Ghana. Bull World Health Organ 74 18-20.
148. FT Cutts, LC Rodrigues, S Colombo and S Bennett (1989) Evaluation of factors influencing vaccine uptake in Mozambique. Int J Epidemiol 18 427-433.
149. FT Cutts, ER Zell, AC Soares and S Diallo (1991) Obstacles to achieving Immunization for All 2000: missed immunization opportunities and inappropriately timed immunization. J Trop Pediatr 37 153-158.
150. JJ Valadez and LH Weld (1992) Maternal recall error of child vaccination status in a developing nation. Am J Public Health 82 120-122.
151. ET Gareaballah and BP Loevinsohn (1989) The accuracy of mothers’ reports about their children's vaccination status. Bull World Health Organ 67 669-674.
152. R Langsten and K Hill (1998) The accuracy of mother's reports of child vaccination: evidence from rural Egypt. Soc Sci Med 46 1205-1212.
153. J Bryce, M Toole, R Waldman and A Voigt (1992) Assessing the quality of facility-based child survival services. Health Policy Plan 7 155-163.
154. Expanded Programme on Immunisation (1997) TechNet Consultation 1996. (WHO/EPI/LHIS/97.02) Geneva: World Health Organization 24.
155. Vaccines, Immunization & Biologicals (2001) Tool for Assessment of Injection Safety (WHO/V&B/01.30) Geneva: World Health Organization.
156. Global Programme for Vaccines and Immunization, Vaccine Research and Development (1996) Monitoring Immunization Services Using the Lot Quality Technique (WHO/VRD/TRAM/96.01) Geneva: World Health Organization
157. CF Lanata, G Stroh, RE Black and H Gonzales (1990) An evaluation of lot quality assurance sampling to monitor and improve immunization coverage. Int J Epidemiol 19 1086-1090.
158. L Rosero-Bixby, C Grimaldo and C Raabe (1990) Monitoring a primary health care programme with lot quality assurance sampling: Costa Rica, 1987. Health Policy Plan 5 30-39.
159. Y Tawfik, S Hoque and M Siddiqi (2001) Using lot quality assurance sampling to improve immunization coverage in Bangladesh. Bull World Health Organ 39 501-505.
160. FT Cutts, PG Smith, S Colombo, et al. (1990) Field evaluation of measles vaccine efficacy in Mozambique. Am J Epidemiol 131 349-355.
161. AL deAndrade, JG deAndrade, CM Martelli, et al. (2004) Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil. Int J Epidemiol 33 173-178.
162. F de la Hoz, AB Higuera, JL Di Fabio, et al. (2004) Effectiveness of Haemophilus influenzae type b vaccination against bacterial pneumonia in Colombia. Vaccine 23 36-42.
163. HF Hull, PJ Williams and F Oldfield (1983) Measles mortality and vaccine efficacy in rural West Africa. Lancet 1 972-975.
164. JB McCormick, N Halsey and R Rosenberg (1977) Measles vaccine efficacy determined from secondary attack rates during a severe epidemic. J Pediatr 90 13-16.
165. J Clemens, R Brenner, M Rao, et al. (1996) Evaluating new vaccines for developing countries. Efficacy or effectiveness, JAMA 275 390-397.
166. KL Nichol, PM Mendelman, KP Mallon, et al. (1999) Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 282 182-184.
167. WA Orenstein, RH Bernier, TJ Dondero, et al. (1985) Field evaluation of vaccine efficacy. Bull World Health Organ 63 1055-1068.
168. WA Orenstein, RH Bernier and AR Hinman (1988) Assessing vaccine efficacy in the field: further observations. Epidemiol Rev 10 212-241.
169. AJ Hall and P Aaby (1990) Tropical trials and tribulations. Int J Epidemiol 19 777-781.
170. RF Breiman, PK Streatfield, M Phelan, et al. (2004) Effect of infant immunization on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data. Lancet 364 2204-2211.
171. JD Clemens, BF Stanton, J Chakraborty, et al. (1988) Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidemiol 128 1330-1339.
172. P Aaby, B Samb, F Simondon, et al. (1995) Non-specific beneficial effect of measles immunization: analysis of mortality studies from developing countries. BMJ 311 481-485.
173. M Garenne, O Leroy, J-P Beau and I Sene (1991) Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 338 903-907.
174. JA Clarkson and PEM Fine (1987) An assessment of methods for routine local monitoring of vaccine efficacy, with particular reference to measles and pertussis. Epidemiol Infect 99 485-499.
175. BD Gessner, A Sutanto, M Linehan, et al. (2005) Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomized vaccine-probe trial. Lancet 365 43-52.
176. F Cutts and D Brown (1995) The contribution of field tests to measles surveillance and control: a review of available methods. Rev Med Virol 5 35-40.
177. G Hlady, J Bennett, A Samadi, et al. (1992) Neonatal tetanus in rural Bangladesh: risk factors and toxoid efficacy. Am J Public Health 82 1354-1369.
178. J Brown, P Djogdom, K Murphy, et al. (1982) Identifying the reasons for low immunization coverage-a case study of Yaounde (United Republic of Cameroon). Rev Epidemiol Sante Publique 30 35-47.
179. A Joseph, S Abraham, S Bhattacharji, et al. (1988) Improving immunization coverage. World Health Forum 9 336-340.
180. K Heggenhougen and J Clements (1987) Acceptability of Childhood Immunization: Social Science Perspectives. A Study Supported by the Expanded Programme on Immunization, World Health Organization (EPC Publication No 14) Evaluation and Planning Centre: London School of Hygiene and Tropical Medicine
181. B Pillsbury (1990) Immunization: The Behavioural Issues (Behavioural Issues in Child Survival Programs Monograph 3) Washington: DC, Office of Health, U.S. Agency for International Development
182. E Eng, J Naimoli, G Naimoli, et al. (1991) The acceptability of childhood immunization to Togolese mothers: a sociobehavioral perspective. Health Educ Q 18 97-110.
183. J Coreil, A Augustin, E Holt and N Halsey (1989) Use of ethnographic research for instrument development in a case-control study of immunization use in Haiti. Int J Epidemiol 18(suppl), S33-S37.
184. D Glik, A Gordon, W Ward, et al. (1987) Focus group methods for formative research in child survival: an Ivoirian example. Int Q Community Health Educ 8 297-316.
185. D Belcher, D Nicholas, S Ofosu-Amaah and F Wurapa (1978) A mass immunization campaign in rural Ghana-factors affecting participation. Public Health Rep 93 170-176.
186. FT Cutts, S Diallo, ER Zell and P Rhodes (1991) Determinants of vaccination in an urban population in Conakry, Guinea. Int J Epidemiol 20 1099-1106.
187. BJ Selwyn (1978) An epidemiological approach to the study of users and non-users of child health services. Am J Public Health 68 231-235.
188. S Zeitlyn, A Mahmudur Rahman, B Nielsen, et al. (1992) Compliance with diphtheria, tetanus, and pertussis immunisation in Bangladesh: factors identifying high-risk groups. BMJ 304 606-609.
189. T van Zwanenberg and C Hull (1988) Improving immunisation coverage in a province in Papua New Guinea. Br Med J (Clin Res Ed) 296 1654-1656.
190. S Zimicki, RC Hornik, CC Verzosa, et al. (1994) Improving vaccination coverage in urban areas through a health communication campaign: the 1990 Philippine experience. Bull World Health Organ 72 409-422.
191. E Pegurri, JA Fox-Rushby and D Walker (2005) Effects, Costs and Cost-effectiveness of Interventions to Expand Coverage of Immunization Services in Developing Countries: A Systematic Review of the Published Literature. Vaccine 23 1624-1635.
192. R Brugha and J Kevany (1995) Immunization determinants in the Eastern Region of Ghana. Health Policy Plan 10 312-318.
193. K Streatfield, M Singarimbun and I Diamond (1990) Maternal education and child immunization. Demography 27 447-455.
194. A Bhuiya, I Bhuiya and M Chowdhury (1995) Factors affecting acceptance of immunization among children in rural Bangladesh. Health Policy Plan 10 304-311.
195. FA Akesode (1982) Factors affecting the use of primary health care clinics for children. J Epidemiol Community Health 36 310-314.
196. K Streatfield and M Singarimbun (1988) Social factors affecting the use of immunization in Indonesia. Soc Sci Med 27 1237-1245.
197. R Hingson (1974) The impact of health beliefs on behavior during an immunization program in rural Haiti, 1972. Health Educ Monogr 2 505-507.
198. P Ulin and R Ulin (1981) The use and non-use of preventive health services in a Southern African village. Int J Health Educ 24 45-53.
199. Expanded Programme on Immunisation (1984) Community participation and immunization coverage. Wkly Epidemiol Rec 59 117-124.
200. N Lin, R Hingson and JA Allwood-Paredes (1971) Mass immunization campaign in El Salvador: evaluation of receptivity and recommendation for future campaigns. Health Rep 86 1112-1121.
201. JEZ Bonilla, JIM Gamarra and EM Booth (1985) Bridging the communication gap-how mothers in Honduras perceive immunization. Assoc Children 69/72 443-454.
202. J Milstien, PD Griffin and J-W Lee (1996) Damage to immunization programmes from misinformation on contraceptive vaccines. Reprod Health Matters 6 24-28.
203. Ryman T, Strategies to strengthen routine immunization coverage: a systematic review of published and gray literature. Submitted for publication
204. K Batt, JA Fox-Rushby and M Castillo-Riquelme (2004) The costs, effects and cost-effectiveness of strategies to increase coverage of routine immunizations in the low- and middle-income countries: a systematic review of the grey literature. Bull World Health Org 82 698.
205. PA Briss, LE Rodewald, AR Hinman, et al. (2000) Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med 18(1 suppl), 97-140.
206. Vaccines, Immunization & Biologicals (2002) Haemophilus influenzae Type B (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distribution, and case fatality rates (WHO/V&B/02.18) Geneva: World Health Organization
207. FT Cutts, RH Henderson, CJ Clements, et al. (1991) Principles of measles control. Bull World Health Organ 69 1-7.
208. AN Kettles (1987) Differences in trends of measles notifications by age and race in the western Cape, 1982–1986. S Afr Med J 72 317-320.
209. FT Cutts, RJ Waldman and HMD Zoffman (1993) Surveillance for the expanded programme on immunization. Bull World Health Organ 71 633-639.
210. FM Laforce, MS Lichnevski, J Keja and RH Henderson (1980) Clinical survey techniques to estimate prevalence and annual incidence of poliomyelitis in developing countries. Bull World Health Organ 58 609-620.
211. B. Vaccines and Biologicals (2002) Protocol for assessing neonatal tetanus mortality in the community using a combination of cluster and lot quality assurance sampling Geneva: World Health Organization (WHO/V&B/02.05).
212. World Health Organization (2006) Validation of neonatal tetanus elimination in Nepal by lot quality assurance-cluster sampling. Weekly Epidemiol Record 81 120-127.
213. Vaccines, Immunization & Biologicals (2001) Introduction of hepatitis b vaccine into childhood immunization services. Management guidelines, including information for health workers and parents (WHO/V&B/01.31) Geneva: World Health Organization
214. Vaccines, Immunization & Biologicals (2001) WHO standards for surveillance of selected vaccine-preventable diseases. Geneva, World Health Organization, 2003 (WHO/V&B/03.01) and Making surveillance work. Module 1: rapid assessment of surveillance for vaccine preventable diseases; Module 3: logistics management; Module 4: data management (WHO/V&B/01.08, 01.10, 01.11) Geneva: World Health Organization
215. RA Adegbola, O Secka, G Lahai, et al. (2005) Elimination of Haemophilus influenzae type b (Hib) disease from the Gambia after the introduction of routine immunization with a Hib conjugate vaccine: a prospective study. Lancet 366 144-150.
216. KT Goh (1996) Hepatitis B immunization in Singapore. Lancet 348 1385-1386.
217. Expanded programme on immunisation (1997) Poliomyelitis eradication: the WHO Global Laboratory Network. Wkly Epidemiol Rec 72 245-249.
218. O. World Health Organization (2005) Laboratory surveillance for wild and vaccine-derived polioviruses, January 2004–June 2005. Weekly Epidemiol Record 39 335-340.
219. RR Frerichs (1989) Simple analytic procedures for rapid microcomputer-assisted cluster surveys in developing countries. Public Health Rep 104 24-35.
220. NJ Gay, LM Hesketh, P Morgan-Capner and E Miller (1995) Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect 115 139-156.
221. P Morgan-Capner, J Wright, CL Miller and E Miller (1989) Surveillance of antibody to measles, mumps, and rubella by age. BMJ 297 770-772.
222. FT Cutts, A Abebe, T Messele, et al. (2000) Serological epidemiology of rubella in urban Ethiopia. Epidemiol Infect 124 467-479.
223. M Ramsay, R Brugha and D Brown (1997) Surveillance of measles in England and Wales: implications of a national saliva testing programme. Bull World Health Organ 75 515-521.
224. DJ Nokes, F Enquselassie, W Nigatu, et al. (2001) Has oral-fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella, and hepatitis B in rural Ethiopia. Bull World Health Organ 79 588-595.
225. RS Azevedo-Neto, ASB Silveira, DJ Nokes, et al. (1994) Rubella seroepidemiology in a non-immunized population of Saõ Paulo State, Brazil. Epidemiol Infect 113 161-173.
226. E Massad, MN Burattini, RS Azevedo-Neto, et al. (1994) A model-based design of a vaccination strategy against rubella in a non-immunized community of Saõ Paulo State, Brazil. Epidemiol Infect 112 579-594.
227. M Ramsay, N Gay, E Miller, et al. (1994) The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev 4(R-12), R141-R146.
228. BT Grenfell and RM Anderson (1985) The estimation of age-related rates of infection from case notifications and serological data. J Hyg (Camb) 95 419-436.
229. Centers for Disease Control and Prevention (2000) Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 49(RR-5), 1-22.
230. O. World Health Organization (2006) Global Safety Advisory Committee on Vaccine Safety, 1–2 December 2005. Weekly Epidemiol Record 81 15-19.
231. O. World Health Organization (2005) Global status of immunization safety: report based on the WHO/UNICEF joint reporting form, 2004 update. Weekly Epidemiol Record 80 361-368.
232. O. World Health Organization (1996) Vaccine supply and quality: Surveillance of adverse events following immunization. Wkly Epidemiol Rec 71 237-241.
233. Vaccines, immunization & biologicals (2000) supplementary information on vaccine safety. Part 1: Field issues; Part 2. Background rates of adverse events following immunization (WHO/V&B/00.24, 00.36) Geneva: World Health Organization
234. L Jodar, P Duclos, JB Milstien, et al. (2001) Ensuring vaccine safety in immunization programs–a WHO perspective. Vaccine 19 1594-1605.
235. Expanded Programme on Immunisation (1989) BCG-associated lymphadenitis in infants. Wkly Epidemiol Rec 48 371-373.
236. KN Praveen, MF Smikle, P Prabhakar, et al. (1990) Outbreak of bacillus Calmette–Guérin–associated lymphadenitis and abscesses in Jamaican children. Pediatr Infect Dis J 9 890-893.
237. Expanded Programme on Immunisation (1988) Lymphadenitis associated with BCG immunization: Mozambique. Wkly Epidemiol Rec 63 381-383.
238. S. Immunization Safety Surveillance (1999) Guidelines for managers of immunization programme on reporting and investigating adverse events following immunization (WPRO/EPI/99.01) Manila: Western Pacific Regional Office, World Health Organization
239. Immunization, Vaccines and Biologicals Aide-memoire on adverse events following immunization: causality assessment—2005. Geneva, World Health Organization. http://www.who.int/vaccines-documents/DocsPDF05/815.pdf
240. World Bank (1993) World Development Report 1993: Investing in Health Oxford: Oxford University Press
241. R Laxminarayan, AJ Mills, JG Breman, et al. (online April 6 2006) Advancement of global health: key messages from the Diseases Control Priority Project. Lancet 1-16.
242. L Brenzel, LJ Wolfson, J Fox-Rushby, et al. (2006) Vaccine preventable diseases. DT Jamison, JG Breman, AT Measham, et al., (Eds) Disease Control Priorities in Developing Countries 2nd edition New York: Oxford University Press 389-411.
243. DT Jamison and H Saxenian (1995) Investing in immunization: conclusions from the 1993 World Development Report. FT Cutts, PG Smith (Eds) Vaccination and World Health Chichester, England: John Wiley 145-160.
244. P Jha, O Bangoura and K Ranson (1998) The cost-effectiveness of forty health interventions in Guinea. Health Policy Plan 13 249-262.
245. KJ Bart, J Foulds and P Patriarca (1996) Global eradication of poliomyelitis: benefit-cost analysis. Bull World Health Organ 74 35-45.
246. D Walker, NR Mosqueira, ME Penny, et al. (2004) Variation in the costs of delivering routine immunization services in Peru. Bull World Health Organ 82 676-682.
247. A Creese and M Dominguez-Uga (1987) Cost-effectiveness of immunization programs in Colombia. Bull Pan Am Health Organ 21 377-394.
248. AJ Hall, RL Robertson, PE Crivelli, et al. (1993) Cost effectiveness of hepatitis B vaccination in The Gambia. Trans R Soc Trop Med Hyg 87 333-336.
249. M Miller and L McCann (2000) Policy analysis of the use of hepatitis B, Haemophilus influenzae type B, streptococcus conjugate and rotavirus vaccines in national immunization schedules. Health Resources 9 19-35.
250. WJ Edmunds, A Dejene, Y Mekonnen, et al. (2000) The cost of integrating hepatitis B vaccine into national immunization programmes: a case study from Addis Ababa. Health Policy Plan 15 408-416.
251. A Creese, N Sriyabbaya, G Casabal and G Wiseso (1982) Cost-effectiveness appraisal of immunization programmes. Bull World Health Organ 60 621-632.
252. O. World Health Organization (2005) WHO-UNICEF guidelines for developing a comprehensive multi-year plan (cMYP). Immunizations, Vaccines and Biologicials Geneva: WHO (WHO/IVB/05.20).
253. World Health Organization. Guidelines for estimating costs of introducing new vaccines into the national immunization program. Geneva, 2002. (WHO/V&B/02.11).
254. O. World Health Organization Immunization Financing website. Information available at. www.who.int/immunization_financing
255. UK Griffiths, G Hutton and E Das Dores Pascoal (2005) The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique. Health Policy Plan 20 50-59.
256. R Robertson, J Davis and K Jobe (1984) Service volume and other factors affecting the costs of immunizations in The Gambia. Bull World Health Organ 62 729-736.
257. C Waddington, A Kello, D Wirakartakusumah, et al. (1989) Financial information at district level: experiences from five countries. Health Policy Plan 4 207-218.
258. RM Anderson and RM May (1982) Directly transmitted infectious diseases: control by vaccination. Science 215 1053-1060.
259. DJ Nokes and RM Anderson (1993) Application of mathematical models to the design of immunization strategies. Rev Med Microbiol 4 1-7.
260. NJ Gay (1998) Modeling measles, mumps, and rubella: implications for the design of vaccination programs. Infect Control Hosp Epidemiol 19 570-573.
261. E Massad, RS Azevedo-Neto, MN Burattini, et al. (1995) Assessing the efficacy of a mixed vaccination strategy against rubella in Saõ Paulo, Brazil. Int J Epidemiol 24 842-850.
262. DJ Nokes and J Swinton (1995) The control of childhood viral infections by pulse vaccination. IMA J Math Appl Med Biol 12 29-53.
263. AR McLean and RM Anderson (1987) Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiol Infect 100 419-441.
264. PEM Fine (1995) The contribution of modeling to vaccination policy. FT Cutts, PG Smith (Eds) Vaccination and World Health Chichester, England: John Wiley 177-192.
265. RM Anderson (1992) The concept of herd immunity and the design of community-based immunization programmes. Vaccine 10 928-935.
266. G DeSerres, NJ Gay and CP Farrington (2000) Epidemiology of transmissible diseases after elimination. Am J Epidemiol 151 1039-1049.
267. WJ Edmunds, GF Medley and DJ Nokes (1996) The transmission dynamics of hepatitis B virus in The Gambia. Stat Med 15 2215-2233.
268. JN Wilson and DJ Nokes (1999) Do we need 3 doses of hepatitis B vaccine? Vaccine 17 2667-2673.
269. WJ Edmunds, GF Medley and DJ Nokes (1999) Evaluating the cost-effectiveness of vaccination programs: a dynamic perspective. Stat Med 18 3263-3282.
270. P Beutels (2001) Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000). Health Econ 10 751-774.
271. R Welte, CL Trotter, WJ Edmunds, MJ Postma and P Beutels (2005) The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine. Pharmacoeconomics 23 855-874.
272. Kim-Farley R and the Expanded Programme on Immunisation Team (1992) Global immunization. Annu Rev Public Health 13 223-237.
273. Global Alliance for Vaccines and Immunizations GAVI Alliance—Progress and Achievements 2005. www.gavialliance.org/resources/FS_Progress___Achievements_en_Jan05.pdf
274. Global Alliance for Vaccines and Immunizations, 17th GAVI Board meeting and joint Alliance Fund Board meeting. http://www.gavialliance.org/Board/Board_Reports/board_docs.php
275. DR Gwatkin, S Rutstein, K Johnson, et al. (2000) Socio-economic Differences in Health, Nutrition and Population in [44 Countries] Washington: DC, Health, Nutrition and Population Department, The World Bank
276. JM Peny, O Gleizes and JP Covilard (2005) Financial requirements of immunization programs in developing countries: a 2004–2014 perspective. Vaccine 31 4610-4618.
277. MA Kane, J Clements, D Hu and B Hepatitis (1993) DT Jamison, WH Mosley, AR Measham, J Bobadilla (Eds) Disease control priorities in developing countries New York: Oxford University Press 321-330.
278. P Van Damme, M Kane and A Meheus (1997) Integration of hepatitis B vaccination into national immunization programmes. BMJ 314 1033-1037.
279. MH Chang, CJ Cen, MS Lai, et al. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336 1855-1859.
280. KT Goh (1997) Prevention and control of hepatitis B virus infection in Singapore. Ann Acad Med Singapore 26 671-681.
281. CJ Clements, B Yang, A Crouch, et al. (2006) Progress in the control of hepatitis B infection in the Western Pacific Region. Vaccine 24 1975-1982.
282. Expanded Programme on Immunisation (1996) Inclusion of yellow fever vaccine in the EPI. Wkly Epidemiol Rec 71 181-188.
283. MC Steinhoff (1997) Haemophilus influenzae type b infections are preventable everywhere. Lancet 349 1186-1187.
284. K Mulholland, S Hilton, R Adegbola, et al. (1997) Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 349 1191-1197.
285. Vaccines, Immunization & Biologicals (2001) Estimating the local burden of Hib disease preventable by vaccination: a rapid assessment tool (WHO/V&B/01.27) Geneva: World Health Organization Available at http://www.who.int/vaccinesdocuments/docspdf/www.675.pdf
286. JB Rosen, et al. (2005) Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines. Malaria Journal 4 53.
287. JB Rosen and JG Breman (2004) Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations. Lancet 363 1386-1388.
288. CA de Quadros, H Izurieta, P Carrasco, et al. (2003) Progress toward measles elimination in the Americas. J Infect Dis (suppl 1), S102-S110.
289. R Biellik, S Madema, A Taole, et al. (2000) First five years of measles elimination in southern Africa: 1996–2000. Lancet 359 1564-1568.
290. A Uzicanin, R Eggers, E Webb, et al. (2002) Impact of the 1996–1997 supplementary measles vaccination campaigns in South Africa. Int J Epidemiol 31 968-976.
291. Expanded Programme on Immunisation (1997) Progress towards measles elimination. Canada. Wkly Epidemiol Rec 72 223-226.
292. M Tobias, S Christie and O Mansoor (1997) Predicting the next measles epidemic. N Z Public Health Rep 4(1),
293. N Gay, M Ramsay, B Cohen, et al. (1997) The epidemiology of measles in England and Wales since the 1994 vaccination campaign. Commun Dis Rep CDR Rev 7(R-2), R17-R21.
294. P Strebel, SL Cochi, M Grabowsky, et al. (2003) The unfinished agenda of measles immunization. J Infect Dis (suppl 1), S1-S7.
295. AM Henao-Restrepo, P Strebel, EJ Hoekstra, et al. (2003) Experience in global measles control, 1990–2001. J Infect Dis (suppl 1), S15-S21.
296. L Wolfson, PM Strebel, M Gacic-Dobo, et al. (2007) Has the 2005 measles mortality reduction goal been achieved? A natural history modeling study. Lancet 369 191-200.
297. Progress towards the global elimination of neonatal tetanus, 1990–1998. Wkly Epidemiol Rec 74 73-80.
298. United Nations Children's Fund (2001) Vaccine security: ensuring a sustained, uninterrupted supply of affordable vaccines (UNICEF/2002/6) New York: United Nations Children's Fund
299. M Greco (2001) Key drivers behind the development of global vaccine market. Vaccine 20 1606-1610.
300. W Vandermissen (2001) WHO expectation and industry goals. Vaccine 19 1611-1615.
301. The Children's Vaccine Initiative and the Global Programme for Vaccines and Immunization (1997) Recommendations from the Scientific Advisory Group of Experts. Part II. Vaccine quality and supply. Wkly Epidemiol Rec 72 249-251.
302. V Dietz, J Milstien, F van Loon, et al. (1996) Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull World Health Organ 74 619-628.
303. Vaccines, Immunization & Biologicals (2000) Report of the Fifth Annual Meeting of the Advisory Committee on Training (ACT) of the Global Training Network, Geneva, February 2000 (WHO/V&B/00.33) Geneva: World Health Organization
304. Vaccines Supply and Quality (1997) A WHO Guide to Good Manufacturing Practice (GMP) Requirements. Part 1: Standard Operating Procedures and Master Formulae; Part 2: Validation (WHO/VSQ/97.01, 97.02) Geneva: World Health Organization
305. S.- Shin Seung-il and G Shahi (1995) Vaccine production and supply in developing countries. FT Cutts, PG Smith (Eds) Vaccination and World Health Chichester, England: John Wiley 39-60.
306. B Aylward, J Lloyd, M Zaffran, et al. (1995) Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies. Bull World Health Organ 73 531-540.
307. M Marmor and P Hartsock (1991) Self-destructing (non-reusable) syringes. Lancet 338 438-439.
308. A Battersby, R Fielden and B Stilwell Vital to health. A briefing document for senior decision makers. Developed for U.S. Agency for International Development, 1998. Available at http://www.childrensvaccine.org/files/Vital_to_Health.pdf
309. JB Milstien, P Evans and A Batson (1995) Vaccine production and supply in developing countries: discussion. FT Cutts, PG Smith (Eds) Vaccination and World Health Chichester, England: John Wiley 60-66.
310. D DeRoeck, SA Bawazar, P Carrasco, et al. (2006) Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program. Int J Health Plann Management 21 23-43.
311. U Parasher and R Glass (2006) Progress toward rotavirus vaccines. Science 312 851-852.
312. M Kaddar, P Lydon and R Levine (2004) Financial challenges of immunization: a look at GAVI. Bull World Health Org 82 697-702.
313. O Barder Vaccines for development. Center for Global Development Brief April 2006, pp1–7. www.cgdev.org
314. D Light (2005) Making practical markets for vaccines. PLOSMedicine 2(10), 934-938. www.plosmedicine.org
315. SE Robertson, FT Cutts, R Samuel and JL Diaz-Ortega (1997) Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 2: vaccination against rubella. Bull World Health Organ 75 69-80.
316. FT Cutts, SE Robertson, JL Diaz-Ortega and R Samuel (1997) Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: burden of disease from CRS. Bull World Health Organ 75 55-68.
317. S Bloom, A Rguig, A Berraho, et al. (2005) Congenital rubella syndrome in Morocco: a rapid retrospective assessment. Lancet 365 135-141.
318. Vaccines, Immunization & Biologicals (2000) Report of a Meeting on Preventing Congenital Rubella Syndrome: Immunization Strategies, Surveillance Needs (WHO/V&B/00.10) Geneva: World Health Organization
319. GL Ada (2001) Vaccines and vaccination. N Engl J Med 345 1042-1053.
320. Immunization, Vaccines, & Biologicals (2006) Proceedings of the Sixth Global Vaccine Research Forum and Parallel Satellite Symposia 2005 (WHO/IVB/06.03) Geneva: World Health Organization
321. J Wenger (2001) Vaccines for the developing world: current status and future directions. Vaccine 19 1588-1591.
322. Centers for Disease Control and Prevention (2000) Preventing pneumococcal disease among infants and young children: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 49(RR-9), 1-35.
323. Centers for Disease Control and Prevention (2005) Control of meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 54(RR-7),
324. E Miller, D Salisbury and M Ramsey (2002) Planning, registration, and implementation of an immunization campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20(suppl), S58-S67.
325. FT Cutts, G Enwere, S Jaffar, et al. (2006) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double blind, placebo controlled trial. Lancet 365 1139-1146.
326. KP Klugman, SA Madhi, RE Huebner, et al. (2003) A trial of nine-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 1341-1348.
327. P.-S. Ruiz-Palacios Perez-Schael, FR Velazquez, et al. (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354 11-22.
328. T Vesikari, DO Matson, P Dennehy, et al. (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354 23-33.
329. TP Monath (2002) Japanese encephalitis vaccines: current vaccines and future prospects. Curr Top Microbiol Immunol 267 105-128.
330. J Hombach, AD Barrett, MJ Cardosa, et al. (2005) Review on flavivirus vaccine development. Proceedings of a meeting jointly organized by the World Health Organization and th eThai Ministry of Public Health, 26–27 April 2004, Bangkok, Thailand. Vaccine 23 2689-2695.
331. H Ohrr, JB Tandan, YM Sohn, et al. (2005) Effect of single dose of SA 14-14-2 vaccine 1 year after immunization in Nepalese children with Japanese encephalitis: a case control study. Lancet 366 1375-1378.
332. PL Alonso, J Sacarlal, JJ Aponte, et al. (2005) Duration of protection with RTS, S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomized controlled trial. Lancet 366 2012-2018.
333. ZH Reed, M Friede and MP Kieny (2006) Malaria vaccine development: progress and challenges. Curr Mol Med 6 231-245.
334. LL Villa, RLR Costa, CA Petta, RP Andrade, et al. (2005) Prophylactic quadrivalent human papillomavirus [types 6, 11, 16 and 18] L1virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase 11 efficacy trial. The Lancet 6 271-278.
335. DM Harper, EL Franco, C Wheeler, DG Ferris, et al. (2004) Efficacy of a bivalentL1-virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 364 1757-1765.
336. DM Harper, EL Franco, CM Wheeler, AB Mosciki, et al. (2006) Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial. Lancet 367 1247-1255. Available at http://www.thelancet.com April 15, 2006
337. JL Bresson, C Perronne, O Launay, et al. (2006) Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet 367(9523), 636-638.
338. CA de Quadros, P Carrasco and J-M Olive (1994) The desired field performance characteristics of new improved vaccines for the developing world. Int J Tech Assoc Health Care 10 1-6.
339. RT Mahoney (2004) Policy analysis: An essential research tool for the introduction of new vaccines in developing countries. J Health Popul Nutr 22 331-337.
340. H. Department of Health (1996) 1996 Immunisation against infectious disease London: Her Majesty's Stationery Office
341. WA Orenstein and RH Bernier (1994) Toward immunizing every child on time. Pediatrics 94 545-547.
342. WA Orenstein and RH Bernier (1994) Crossing the divide from vaccine technology to vaccine delivery: the critical role of providers. JAMA 272 1138-1139.
343. Interagency Committee to Improve Access to Immunization Services (1992) The Public Health Service action plan to improve access to immunization services. Public Health Rep 107 243-251.
344. Ad Hoc Working Group for the Development of Standards for Pediatric Immunization Practices (1993) Standards for pediatric immunization practices. JAMA 269 1817-1822. (Updates posted on CDC's National Immunization Program Internet site [ www.cdc.gov/nip]).
345. FT Cutts, ER Zell, D Mason, et al. (1992) Monitoring progress towards U.S. preschool immunization goals. JAMA 267 1952-1955.
346. P Szilagyi, L Rodewald, S Humiston, et al. (1993) Missed opportunities for childhood vaccinations in office practices and the effect on vaccination status. Pediatrics 91 1-7.
347. D Bishai, S Bhatt, LT Miller, et al. (1992) Vaccine storage practices in paediatric offices. Pediatrics 89 193-196.
348. H Briggs and S Ilett (1993) Weak link in vaccine cold chain. BMJ 306 557-558.
349. WHO (2002) Tough choices: investing in health for development. Experiences from national follow-up to the commission on macroeconomics and health Geneva: WHO
350. MM Khan, SH Khan, D Walker, et al. (2004) Cost of delivering child immunization services in urban Bangladesh: a study based on facility level surveys. J Health Popul Nutr 22 404-412.
351. R Fielden and OF Nielson (2001) Immunization and Health Reforms: Making Reforms Work for Immunization. A Reference Guide (WHO/V&B/01.44) Geneva: World Health Organization
352. EJ Gangarosa, AM Galazka, CR Wolfe, et al. (1998) Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 351 356-361.
353. United Nations Children's Fund Combating Anti-vaccination Rumors: Lessons Learned from Case Studies in East Africa. New York, United Nations Children's Fund, 2001. Available at www.comminit.com/strumoursvacc/sld5095.html
354. KM Madsen, A Hvid, M Vestergaard, et al. (2002) A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347 1477-1482.
355. J Bryce, C Boschi-Pinto, K Shibuya, et al. (2005) WHO estimates of the causes of death in children. Lancet 365 1147-1152.
356. Seventh Consultative Committee on Primary Health Care Systems for the 21st Century. Health care systems for the 21st century. BMJ 314 1407-1409.